Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)-Reference-Cited by-同舟云学术

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M3P)

Published:2015-03-07 Issue:7 Volume:94 Page:1205-1211
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Kortüm K. M.,Langer C.,Monge J.,Bruins L.,Zhu Y. X.,Shi C. X.,Jedlowski P.,Egan J. B.,Ojha J.,Bullinger L.,Kull M.,Ahmann G.,Rasche L.,Knop S,Fonseca R.,Einsele H.,Stewart A. K.,Braggio Esteban

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-015-2344-9.pdf

Reference26 articles.

1. Brioli A, Melchor L, Cavo M, Morgan GJ (2014) The impact of intra-clonal heterogeneity on the treatment of multiple myeloma. Br J Haematol 165(4):441–454. doi: 10.1111/bjh.12805

2. Egan JB, Shi CX, Tembe W, Christoforides A, Kurdoglu A, Sinari S, Middha S, Asmann Y, Schmidt J, Braggio E, Keats JJ, Fonseca R, Bergsagel PL, Craig DW, Carpten JD, Stewart AK (2012) Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides. Blood 120(5):1060–1066. doi: 10.1182/blood-2012-01-405977

3. Melchor L, Brioli A, Wardell CP, Murison A, Potter NE, Kaiser MF, Fryer RA, Johnson DC, Begum DB, Hulkki Wilson S, Vijayaraghavan G, Titley I, Cavo M, Davies FE, Walker BA, Morgan GJ (2014) Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma. Leukemia 28(8):1705–1715. doi: 10.1038/leu.2014.13

4. Keats JJ, Chesi M, Egan JB, Garbitt VM, Palmer SE, Braggio E, Van Wier S, Blackburn PR, Baker AS, Dispenzieri A, Kumar S, Rajkumar SV, Carpten JD, Barrett M, Fonseca R, Stewart AK, Bergsagel PL (2012) Clonal competition with alternating dominance in multiple myeloma. Blood 120(5):1067–1076. doi: 10.1182/blood-2012-01-405985

5. Lonial S, Yellapantula VD, Liang W, Kurdoglu A, Aldrich J, Legendre CM, Stephenson K, Adkins J, McDonald J, Helland A, Russell M, Christofferson A, Cuyugan L, Rohrer D, Blanski A, Hodges M, CoMMpass Network M, Derome M, Auclair D, Kidd PG, Jewell S, Craig D, Carpten J, Keats JJ (2014) Interim analysis of the Mmrf Commpass Trial: identification of novel rearrangements potentially associated with disease initiation and progression. Blood 124(21):722–722

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Targeted Panel of 282 Genes: Unveiling Key Biomarkers in Multiple Myeloma;2023-11-01

2. Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines;Frontiers in Oncology;2022-11-29

3. Liquid Biopsy-Derived DNA Sources as Tools for Comprehensive Mutation Profiling in Multiple Myeloma: A Comparative Study;Cancers;2022-10-07

4. Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma;Cancer Immunology Research;2022-09-19

5. The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma;Translational Oncology;2022-08